Back to top
Pamorelin LA 22.5 mg Injection
Pamorelin LA 22.5 mg Injection

Pamorelin LA 22.5 mg Injection

Pamorelin LA 22.5 mg Injection Specification

  • Salt Composition
  • Triptorelin Acetate
  • Origin of Medicine
  • Synthetic
  • Pacakaging (Quantity Per Box)
  • 1 Vial per Box
  • Drug Type
  • Hormonal Therapy Injection
  • Ingredients
  • Triptorelin 22.5 mg
  • Physical Form
  • Injection
  • Function
  • Treatment of Prostate Cancer and Endometriosis
  • Recommended For
  • Patients with Prostate Cancer Endometriosis or Other Hormonal Imbalances
  • Dosage
  • 22.5 mg
  • Dosage Guidelines
  • Administered once every three months under medical supervision
  • Suitable For
  • Adults
  • Quantity
  • Single Vial
  • Storage Instructions
  • Store in a refrigerator between 2C and 8C protected from light
 
 

About Pamorelin LA 22.5 mg Injection



Pamorelin LA 22.5 mg Injection is a synthetic hormonal therapy injection containing Triptorelin Acetate. It is designed for the treatment of prostate cancer and endometriosis in adults. Each box contains a single vial of 22.5 mg dosage, recommended for patients with hormonal imbalances. Administered once every three months under medical supervision, this injection offers convenience and efficacy. To maintain its potency, store Pamorelin LA in a refrigerator between 2C and 8C, shielded from light.

FAQs of Pamorelin LA 22.5 mg Injection:


Q: What is the primary function of Pamorelin LA 22.5 mg Injection?

A: Pamorelin LA is primarily used for the treatment of prostate cancer and endometriosis in adult patients.

Q: How often should Pamorelin LA 22.5 mg Injection be administered?

A: It is recommended to administer Pamorelin LA once every three months under medical supervision.

Q: What is the storage requirement for Pamorelin LA 22.5 mg Injection?

A: Pamorelin LA should be stored in a refrigerator between 2C and 8C, protected from light.

Q: What is the composition of Pamorelin LA 22.5 mg Injection?

A: Pamorelin LA contains Triptorelin Acetate as its salt composition in a 22.5 mg dosage.

Q: Who is Pamorelin LA 22.5 mg Injection suitable for?

A: Pamorelin LA is suitable for adults with prostate cancer, endometriosis, or other hormonal imbalances.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Gynaecology Category

Pamorelin LA 11.25 mg Injection

Pamorelin LA 11.25 mg Injection

Salt Composition : Triptorelin Pamoate

Physical Form : Liquid

Origin of Medicine : Synthetic

Recommended For : Patients with prostate cancer

Quantity : One singleuse vial

Dosage Guidelines : Administered as an intramuscular injection every 3 months or as directed by the healthcare provider

Letroz 2.5 mg Tablet

Letroz 2.5 mg Tablet

Salt Composition : Letrozole

Physical Form : Tablet, Other

Origin of Medicine : Synthetic

Recommended For : Postmenopausal women diagnosed with hormone receptorpositive breast cancer

Quantity : 10 tablets per strip

Dosage Guidelines : Take as directed by the healthcare provider preferably at the same time each day

Estogel 80 gm Cream

Estogel 80 gm Cream

Salt Composition : Estradiol hemihydrate

Physical Form : Other, Cream

Origin of Medicine : Synthetic

Recommended For : Postmenopausal women requiring estrogen replacement

Quantity : 80 gm

Dosage Guidelines : Apply on clean dry skin on areas such as thighs or arms. Do not apply on breasts.

Lupride Depot 11.25 mg Injection

Lupride Depot 11.25 mg Injection

Salt Composition : Leuprolide Acetate

Physical Form : Other, Injection

Origin of Medicine : Synthetic

Recommended For : Patients with prostate cancer endometriosis or hormonerelated conditions

Quantity : 1 vial per package

Dosage Guidelines : Administered as prescribed by a healthcare professional; typically given once every 3 months